Scalable industrial bioreactor for new food ingredient fermentation
Tetra Pak has introduced a fermentation vessel to lower operational costs and maintain stable process conditions across multiple scales of production.
www.tetrapak.com
Producers face significant risks when scaling up biochemical processes, particularly regarding batch consistency and mechanical reliability. Fluctuations in process conditions can lead to complete batch failure, with losses valued at approximately 1,000 euros per cubic meter. Traditional designs often suffer from process instability and contamination risks stemming from mechanical seals. To mitigate these issues, the industry requires highly automated systems capable of ensuring repeatable performance during the conversion of raw materials into food ingredients.
Magnetic agitation and automated process stabilization
The newly developed equipment utilizes a patented magnetic agitation system that completely removes the need for mechanical seals. This design choice minimizes contamination vectors while maintaining uniform torque and oxygen transfer across all vessel volumes, which range from 10 to 50,000 liters. The system operates on a single design platform with unified control logic and operating philosophy, simplifying cross-site operator training and routine management.
Furthermore, self-adjusting control automation functions stabilize environmental variables as the fermentation process evolves, reducing the necessity for manual interventions. Integrated data monitoring and predefined operating strategies provide operators with enhanced process visibility and efficiency. The modular configuration also allows adjustments to alarm thresholds and impellers as production requirements change over time.
Economic impact and installation efficiency
The hardware architecture features an integrated platform design that removes the need for separate support structures, lowering installation complexity. Because the units are pre-assembled and factory-tested, commissioning is accelerated, reducing disruptions to production planning. These integration features lower initial investment expenses by up to 8% compared to conventional bioreactors. Additionally, the combination of automated stabilization, reduced contamination risks, and simplified operation helps producers lower total operational costs by up to 12%.
Edited by Lekshman Ramdas, Induportals editor – adapted by AI.
www.tetrapak.com
